IME logo

Imagin Medical Inc. Stock Price

CNSX:IME Community·CA$162.5k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

IME Share Price Performance

CA$0
0.00 (0.00%)
CA$0
0.00 (0.00%)
Price CA$0

IME Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Weak fundamentals or lack of information.

5 Risks
1 Reward

Imagin Medical Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$3.3m

Other Expenses

-CA$3.3m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
-0.31
0%
0%
-91.8%
View Full Analysis

About IME

Founded
1986
Employees
n/a
CEO
Edward Hutchens
WebsiteView website
imaginmedical.com

Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer. The company is also developing technologies to visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. It has a license agreement with Lawrence Livermore National Security, LLC to develop and commercialize the i/Blue Imaging System. The company was founded in 1986 and is headquartered in Vancouver, Canada.

Recent IME News & Updates

Recent updates

No updates